Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.

Guglielmetti, Lorenzo; Günther, Gunar; Leu, Claude; Cirillo, Daniela; Duarte, Raquel; Garcia-Basteiro, Alberto L; Goletti, Delia; Jankovic, Mateja; Kuksa, Liga; Maurer, Florian P; Méchaï, Frédéric; Tiberi, Simon; van Leth, Frank; Veziris, Nicolas; Lange, Christoph (2022). Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. The European respiratory journal, 59(5) European Respiratory Society 10.1183/13993003.00388-2022

[img] Text
2200388.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Author holds Copyright

Download (634kB)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Günther, Gunar

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1399-3003

Publisher:

European Respiratory Society

Language:

English

Submitter:

Pubmed Import

Date Deposited:

20 May 2022 15:27

Last Modified:

05 Dec 2022 16:19

Publisher DOI:

10.1183/13993003.00388-2022

PubMed ID:

35589114

BORIS DOI:

10.48350/170127

URI:

https://boris.unibe.ch/id/eprint/170127

Actions (login required)

Edit item Edit item
Provide Feedback